Picture of Avanos Medical logo

AVNS — Avanos Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Avanos Medical Inc expected to post earnings of 38  cents a share - Earnings Preview

* Avanos Medical Inc  AVNS.N   AVNS.K  is expected to show a
rise
in quarterly revenue when it reports  results on August 9. 
    * The Alpharetta Georgia-based  company is expected to
report  a
11.7% increase in revenue to $208.275 million from $186.4
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Avanos Medical Inc
is for
earnings of 38 cents per share. For the same quarter last year,
the company reported earnings of 21 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Avanos
Medical
Inc is $34.5​, above​ its last closing price of $28.43. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  0.26        0.26       0.26      Met     0
 Dec. 31 2022  0.40        0.40       0.46      Beat    14.4
 Sep. 30 2021  0.29        0.30       0.25      Missed  -17.1​
 Jun. 30 2021  0.23        0.23       0.21      Missed  -10
 ​​Mar.        0.18        0.19       0.23      Beat    24.3
 31 2021                                                
 Dec. 31 2020  0.22        0.22       0.28      Beat    29.2​
 Sep. 30 2020  0.11        0.10       0.21      Beat    110
 Jun. 30 2020  -0.08       -0.10      0.13      Beat    230
 This summary was machine generated July 29 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Avanos Medical

See all news